Transforming growth factor-β1 triggers hepatocellular carcinoma invasiveness via α3β1 integrin

American Journal of Pathology

Volumn 161, Issue 1, 2002, Pages 183-193

  Giannelli, G ^b   Fransvea, E ^b   Marinosci, F ^b   Bergamini, C ^b   Colucci, S ^b   Schiraldi, O ^b   Antonaci, S ^b  

^a POLICLINICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; INTEGRIN; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3;

ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER PARENCHYMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0036317838     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64170-3     Document Type: Article

References (49)

1. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
2. Hepatocellular carcinoma
3. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States
4. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection
5. Integrins: A family of cell surface receptors
6. Integrins and tumor cell dissemination
7. New insights into integrin-ligand interaction
8. Integrins
9. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis
10. Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors
11. Altered expression of basement membrane proteins and their integrin receptors in lichen planus: Possible pathogenetic role of gelatinases A and B
12. Role of extracelluar matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver
13. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion
14. Biological and clinical relevance of laminin-5 in cancer
15. Laminin-5 as a marker of invasiveness in cervical lesions
16. Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment
17. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas
18. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity
19. Matrix metalloproteinases and metastasis
20. Matrix metalloproteinases and the development of cancer
21. Basement membrane production by hepatocytes in chronic liver disease
22. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma
23. Alpha3beta1-integrin as a critical mediator of the hepatic differentiation response to the extracellular matrix
24. Alpha6beta1 integrin expression in hepatocarcinoma cells: Regulation and role in cell adhesion and migration
25. Fibrolamellar carcinoma of the liver: Composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules
26. Molecular mechanisms of transforming growth factor-beta signaling
27. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis
28. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy
29. A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors
30. Changes in expression of monoclonal antibody epitopes on laminin-5r induced by cell contact
31. Localization of the alpha 3 beta 1 integrin in some common epithelial tumors of the ovary and in normal equivalents
32. Production and characterization of two monoclonal antibodies directed against the integrin beta 1 chain
33. Polarization of the alpha 6 beta 4 integrin in ovarian carcinomas
34. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
35. Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): Characterization of complex and free enzyme
36. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5
37. A rapid in vitro assay for quantitating the invasive potential of tumor cells
38. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis
39. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma
40. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma
41. TGF-beta 1 modulated the expression of alpha 5 beta 1 integrin and integrin-mediated signaling in human hepatocarcinoma cells
42. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes
43. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule
44. TGF-beta plays a key role in morphogenesis of the pancreatic islets of Langerhans by controlling the activity of the matrix metalloproteinase MMP-2
45. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression
46. Serum levels of transforming growth factor beta1 in patients with breast cancer
47. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity
48. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma
49. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy